News
12-15-2010, 09:05 AM
Genomic Health, Inc. (Nasdaq: GHDX) announced results from seven new studies focusing on its multigene Oncotype DX® breast cancer test, which has helped guide treatment decisions in more than 175,000 breast cancer patients worldwide...
More... (http://mnt.to/f/3P6s)
More... (http://mnt.to/f/3P6s)